Purity percentage is one of the first specifications researchers examine when evaluating a research peptide. Equally important — yet sometimes less discussed — is confirmation of molecular identity. High-performance liquid chromatography (HPLC) tells us how pure a sample is; mass spectrometry (MS) tells us whether the main component is actually the intended peptide.
Why Identity Confirmation Matters
During solid-phase peptide synthesis, a range of process-related impurities can form, including deletion sequences, truncated peptides, incompletely deprotected species, or side-reaction products. An HPLC chromatogram may show a dominant peak at high purity, but without identity confirmation it is impossible to know with certainty that the peak corresponds to the correct molecular weight and sequence.
Mass spectrometry addresses this by measuring the mass-to-charge ratio of the peptide ions. The observed molecular weight is then compared to the theoretical mass calculated from the intended amino acid sequence. A close match (typically within a very narrow tolerance) provides strong evidence that the correct peptide has been produced.
How Mass Spectrometry Complements HPLC
- HPLC separates components and quantifies relative purity based on UV absorbance.
- Mass spectrometry confirms that the primary component has the expected exact mass.
- When used together, the two techniques offer a more complete picture: the material is both highly pure and the right molecule.
In more advanced workflows, tandem mass spectrometry (MS/MS) or other sequence-verification methods can provide additional structural confirmation, particularly for complex or modified peptides.
What Researchers Should Look for on a COA
A robust Certificate of Analysis for research peptides typically includes:
- Theoretical molecular weight
- Observed molecular weight from mass spectrometry
- Confirmation that the values match within accepted analytical limits
- Clear identification of the testing method and laboratory Batch-specific reporting ensures the data applies directly to the material in the vial.
How Phorm Labs Incorporates Mass Spectrometry
At Phorm Labs, mass spectrometry is a standard component of the multi-level quality verification process. Every batch undergoes independent testing that includes:
- Analytical HPLC for purity (≥98–99.5%+)
- Mass spectrometry for exact molecular weight match
- Endotoxin testing via LAL assay
- Additional parameters as required
Results are documented on a batch-specific Certificate of Analysis, giving researchers transparent, traceable evidence of both purity and identity.
Supporting Confidence in Experimental Materials
When the identity of a research peptide is independently verified, scientists can attribute experimental observations more confidently to the intended compound rather than to an unknown or incorrect species. This level of analytical rigor forms a foundational element of reproducible laboratory work.
Explore the Phorm Labs catalog to view research peptides produced under controlled synthesis conditions and verified through comprehensive third-party testing, including mass spectrometry. All products are supplied strictly for qualified laboratory research and analytical applications.
Purity shows how clean it is. Mass spectrometry confirms what it is.
This content is provided for educational purposes regarding analytical verification of research peptides. All Phorm Labs products are for research use only and are not intended for human consumption, diagnostic, or therapeutic use.

